Norges Bank’s Boston Scientific BSX Stock Holding History

Norges Bank’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,066,546	Closed	-$2.2B	–	217
2025 Q4	$2.2B	Buy	+23,066,546	New	+$2.26B	0.24%	76
2025 Q3	–	Sell	-19,457,562	Closed	-$2.09B	–	248
2025 Q2	$2.09B	Sell	19,457,562 -512,102	-3%	-$51.8M	0.26%	70
2025 Q1	$2.01B	Buy	19,969,664 +236,991	+1%	+$23.9M	0.28%	63
2024 Q4	$1.76B	Buy	19,732,673 +643,266	+3%	+$56.6M	0.23%	72
2024 Q3	$1.6B	Buy	19,089,407 +1,212,381	+7%	+$95.6M	0.22%	80
2024 Q2	$1.38B	Buy	17,877,026 +366,822	+2%	+$26.8M	0.21%	87
2024 Q1	$1.2B	Buy	17,510,204 +1,412,191	+9%	+$90.8M	0.19%	105
2023 Q4	$931M	Buy	16,098,013 +1,537,427	+11%	+$82.1M	0.16%	129
2023 Q3	$769M	Buy	14,560,586 +167,454	+1%	+$8.78M	0.16%	129
2023 Q2	$779M	Buy	14,393,132 +330,068	+2%	+$17.2M	0.15%	128
2023 Q1	$704M	Buy	14,063,064 +392,857	+3%	+$18.5M	0.15%	130
2022 Q4	$633M	Buy	13,670,207 +344,285	+3%	+$14.9M	0.15%	138
2022 Q3	$516M	Buy	13,325,922 +926,565	+7%	+$37.2M	0.14%	152
2022 Q2	$462M	Sell	12,399,357 -971,816	-7%	-$39.6M	0.12%	172
2022 Q1	$592M	Buy	13,371,173 +115,346	+0.9%	+$5M	0.13%	154
2021 Q4	$563M	Sell	13,255,827 -482,519	-4%	-$20.3M	0.12%	168
2021 Q3	$596M	Sell	13,738,346 -438,465	-3%	-$19.4M	0.13%	148
2021 Q2	$606M	Sell	14,176,811 -508,028	-3%	-$21.4M	0.13%	154
2021 Q1	$568M	Buy	14,684,839 +502,993	+4%	+$19M	0.13%	156
2020 Q4	$510M	Buy	14,181,846 +646,346	+5%	+$23.3M	0.12%	165
2020 Q3	$517M	Buy	13,535,500 +419,547	+3%	+$16.2M	0.14%	139
2020 Q2	$461M	Buy	13,115,953 +1,152,685	+10%	+$41.5M	0.13%	147
2020 Q1	$390M	Sell	11,963,268 -2,893,729	-19%	-$113M	0.14%	141
2019 Q4	$672M	Hold	14,856,997	–	–	0.19%	103
2019 Q3	$605M	Buy	14,856,997 +302,280	+2%	+$12.8M	0.19%	107
2019 Q2	$626M	Sell	14,554,717 -212,601	-1%	-$8.18M	0.19%	98
2019 Q1	$567M	Buy	14,767,318 +1,497,870	+11%	+$57.2M	0.18%	108
2018 Q4	$469M	Sell	13,269,448 -4,625,805	-26%	-$168M	0.17%	117
2018 Q3	$689M	Buy	17,895,253 +154,754	+0.9%	+$5.41M	0.22%	84
2018 Q2	$580M	Sell	17,740,499 -872,491	-5%	-$26.3M	0.2%	96
2018 Q1	$509M	Buy	18,612,990 +1,993,939	+12%	+$54.2M	0.18%	108
2017 Q4	$412M	Sell	16,619,051 -535,956	-3%	-$14.8M	0.15%	139
2017 Q3	$500M	Buy	17,155,007 +425,000	+3%	+$11.7M	0.19%	113
2017 Q2	$464M	Buy	16,730,007 +873,796	+6%	+$23.2M	0.18%	112
2017 Q1	$394M	Buy	15,856,211 +1,904,572	+14%	+$46.3M	0.16%	124
2016 Q4	$302M	Buy	13,951,639 +1,374,178	+11%	+$30M	0.13%	156
2016 Q3	$286M	Buy	12,577,461 +2,179,597	+21%	+$52M	0.14%	146
2016 Q2	$243M	Buy	10,397,864 +659,007	+7%	+$14.3M	0.12%	177
2016 Q1	$183M	Sell	9,738,857 -813,706	-8%	-$14.3M	0.09%	212
2015 Q4	$195M	Sell	10,552,563 -1,122,700	-10%	-$20.1M	0.1%	202
2015 Q3	$192M	Buy	11,675,263 +160,755	+1%	+$2.75M	0.1%	191
2015 Q2	$204M	Buy	11,514,508 +284,716	+3%	+$5.09M	0.1%	194
2015 Q1	$199M	Buy	11,229,792 +829,286	+8%	+$13.1M	0.1%	205
2014 Q4	$138M	Buy	10,400,506 +150,944	+1%	+$1.93M	0.07%	270
2014 Q3	$121M	Sell	10,249,562 -10,138,450	-50%	-$128M	0.07%	286
2014 Q2	$260M	Buy	20,388,012 +10,194,006	+100%	+$133M	0.07%	263
2014 Q1	$138M	Hold	10,194,006	–	–	0.08%	241
2013 Q4	$123M	Sell	10,194,006 -3,820,503	-27%	-$45.1M	0.07%	268
2013 Q3	$165M	Buy	14,014,509 +9,452,335	+207%	+$102M	0.1%	208
2013 Q2	$42.3M	Buy	+4,562,174	New	+$38.7M	0.03%	593

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank's BSX Position: Q1 2026 in Review

Norges Bank sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 23,066,546 shares — an estimated $2.2B sold.

Norges Bank first reported a position in BSX in Q2 2013 and held it in 50 quarters. The position peaked at $2.2B in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Norges Bank reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 23,066,546 Boston Scientific shares in Q1 2026, an estimated $2.2B.
Norges Bank first reported a position in Boston Scientific in Q2 2013 and held it in 50 quarters.
Norges Bank's Boston Scientific position peaked at $2.2B in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.